Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 3
2020 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Holicek P, Truxova I, Rakova J, Salek C, Hensler M, Kovar M, Reinis M, Mikyskova R, Pasulka J, Vosahlikova S, Remesova H, Valentova I, Lysak D, Holubova M, Kaspar P, Prochazka J, Kasikova L, Spisek R, Galluzzi L, Fucikova J. Holicek P, et al. Among authors: remesova h. Cell Death Dis. 2023 Mar 24;14(3):209. doi: 10.1038/s41419-023-05728-w. Cell Death Dis. 2023. PMID: 36964168 Free PMC article.
ABC transporters are predictors of treatment failure in acute myeloid leukaemia.
Cerovska E, Salek C, Kundrat D, Sestakova S, Pesek A, Brozinova I, Belickova M, Remesova H. Cerovska E, et al. Among authors: remesova h. Biomed Pharmacother. 2024 Jan;170:115930. doi: 10.1016/j.biopha.2023.115930. Epub 2023 Nov 30. Biomed Pharmacother. 2024. PMID: 38039756 Free article.
A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel.
Šestáková Š, Cerovská E, Šálek C, Kundrát D, Ježíšková I, Folta A, Mayer J, Ráčil Z, Cetkovský P, Remešová H. Šestáková Š, et al. Among authors: remesova h. Clin Epigenetics. 2022 Feb 11;14(1):22. doi: 10.1186/s13148-022-01242-6. Clin Epigenetics. 2022. PMID: 35148810 Free PMC article.
Prognostic significance of mutation profile at diagnosis and mutation persistence during disease remission in adult acute myeloid leukaemia patients.
Folta A, Culen M, Jeziskova I, Herudkova Z, Tom N, Hlubinkova T, Janeckova V, Durinikova A, Vydra J, Semerad L, Dvorakova D, Remesova H, Cerovska E, Cetkovsky P, Jindra P, Szotkowski T, Zak P, Mayer J, Racil Z. Folta A, et al. Among authors: remesova h. Br J Haematol. 2019 Jul;186(2):300-310. doi: 10.1111/bjh.15916. Epub 2019 Apr 9. Br J Haematol. 2019. PMID: 30968396 Free article. Clinical Trial.
WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia.
Šálek C, Vydra J, Cerovská E, Šestáková Š, Ransdorfová Š, Válková V, Cetkovský P, Remešová H. Šálek C, et al. Among authors: remesova h. Clin Lymphoma Myeloma Leuk. 2020 Dec;20(12):e998-e1009. doi: 10.1016/j.clml.2020.07.014. Epub 2020 Aug 10. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32888885
Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes.
Merkerova MD, Remesova H, Krejcik Z, Loudova N, Hrustincova A, Szikszai K, Cermak J, Jonasova A, Belickova M. Merkerova MD, et al. Among authors: remesova h. Cells. 2018 Sep 14;7(9):138. doi: 10.3390/cells7090138. Cells. 2018. PMID: 30223454 Free PMC article.